Artwork for Cancer Connections
Science

Cancer Connections

Cancer Research Horizons

A podcast by Cancer Research Horizons, the commercial arm of Cancer Research UK, hosted by healthcare leader Parker Moss.

In each episode, Parker will be sitting down with members of Cancer Research Horizons’ world-class Expert Network to explore the human stories and connections helping us drive cutting-edge science towards patient benefit.

As we delve into the journeys that have shaped our experts’ careers, we will uncover the latest breakthroughs in oncology, hard-won lessons in commercialisation, and the depth of the ecosystem needed to take discoveries all the way to life-changing treatment.

Cancer Connections aims to inspire more brilliant minds to help us go further, together, in our mission to beat cancer.

  • 2 episodes
  • Updated Tuesday

Episodes2

  • Tuesday · 26 min

    Ep.1 with Dr Simon Boulton: From Discovery Scientist to Two-Time Biotech Founder

    How does a discovery scientist become a two-time biotech founder? In the inaugural episode of Cancer Connections, Parker Moss sits down with Dr Simon Boulton, a world-renowned scientist whose work in DNA damage repair and telomere maintenance has transformed our understanding of how cancer develops—and how we can better treat it. Although a research scientist by training, Simon recognised the therapeutic potential of his discoveries and went on to co-found Artios Pharma and, more recently, launch ALTx Therapeutics, taking breakthrough research from the lab towards meaningful patient impact. Together, they explore what motivates someone to take that leap from academia into entrepreneurship, the importance of the people you work with, learn from, and build alongside, and what it really takes to translate cutting-edge science into new medicines for patients.

  • July 14 · 20 min

    Trailer: Meet your host, Parker Moss

    Before the conversations begin, meet the voice behind Cancer Connections. In this trailer episode, host Parker Moss shares the personal and professional journey that led him into cancer innovation. From a career in technology and venture capital to a deeply personal experience with childhood cancer, Parker reflects on the experiences that shaped his commitment to improving outcomes for patients with cancer. He discusses the breakthroughs in cancer research that have him most excited, why collaboration across science, medicine, industry and investment is crucial to turning discoveries into patient benefit, and what he hopes to uncover through conversations with members of the Cancer Research Horizons Expert Network. Because, as Parker says, “it really takes a village to bring a cancer drug to market.”